Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

GSK1349572 Drug Interaction Study With Fosamprenavir/Ritonavir

This study has been completed.
Sponsor:
Collaborator:
GlaxoSmithKline
Information provided by (Responsible Party):
ViiV Healthcare
ClinicalTrials.gov Identifier:
NCT01209065
First received: August 30, 2010
Last updated: September 8, 2016
Last verified: September 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: November 2010
  Primary Completion Date: November 2010 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):